All In Biotech

Drug Trial Radar · NCT07808268

A Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution in Adult Participants With Respiratory Syncytial Virus Infection

Last checked: Nov 20, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Oct 10, 2026

Primary completion

Dec 10, 2027

Study completion Mar 10, 2028

Sponsor

Sponsor type
Industry
First posted
Sep 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase II clinical study to evaluate the efficacy and safety of YKYY018 for inhalation solution in adult participants with respiratory syncytial virus infection

Conditions

  • Respiratory Syncytial Virus (RSV)

Interventions

  • YKYY018 for Inhalation SolutionDrug

    nebulized inhalation, QD or Q2D of the corresponding dose of YKYY018 for inhalation solution

  • YKYY018 PlaceboDrug

    nebulized inhalation, QD or Q2D of the corresponding dose of YKYY018 placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The time from initial administration to symptom relief of lower respiratory symptoms on the RiiQ (Respiratory Intensity and Impact Questionnaire) symptom scaleTime frame: within 28 days after administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.